Pemetrexed: all 524 studies that test it
Page 5 of 6. Open to participants first (73), then studies with results posted, then the rest; newest registration first within each.
- A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer PatientsCompletedNCT01531790Phase 1
- A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung CancerCompletedNCT01496742Phase 2
- Pemetrexed and Cisplatin in Advanced Urothelial CarcinomaCompletedNCT01490437Phase 2
- Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid TumorsCompletedNCT01450384Phase 1
- Pemetrexed Followed by Docetaxel or in Reverse SequenceCompletedNCT01442909Phase 4
- An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal CancerCompletedNCT01397305Phase 1/2
- Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung CancerTerminatedNCT01356368Phase 2
- Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid TumorsCompletedNCT01336842Phase 1
- Consolidation Chemotherapy/Concurrent Chemo-radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer (NSCLC)WithdrawnNCT01336543Phase 2
- Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and NeckStatus unknownNCT01333696Phase 2
- A Study of the Safety and Pharmacology of GDC-0980 in Combination With Either Paclitaxel and Carboplatin (With or Without Bevacizumab) or Pemetrexed and Cisplatin in Patients With Solid TumorsCompletedNCT01301716Phase 1
- Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer PatientsStatus unknownNCT01192243Phase 2
- Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-PaclitaxelCompletedNCT01192165Phase 1
- A Study of RO5083945 in Combination With Chemotherapy Versus Chemotherapy Alone in Patients With Advanced or Recurrent Non-Small Cell Lung CancerCompletedNCT01185847Phase 2
- Phase II Trial of Pemetrexed-Based Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Previously Irradiated Head and Neck Cancer PatientsCompletedNCT01172470Phase 2
- Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT01172028Phase 1
- Ixabepilone and Pemetrexed/Solid TumorsWithdrawnNCT01170871Phase 1
- Trial of Pemetrexed in Combined With Cisplatin for the Treatment of Advanced Breast CancerCompletedNCT01143974Phase 4
- Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).CompletedNCT01116219Phase 2
- Pemetrexed and Gemcitabine for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS MutationsTerminatedNCT01109615Phase 2
- AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural MesotheliomaWithdrawnNCT01105390Phase 2
- Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung CancerCompletedNCT01004601Not applicable
- A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00974584Phase 1
- TS Gene Polymorphism Predicts Effect in Patients With Advanced Lung CancerCompletedNCT00940069Phase 2
- Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung CancerStatus unknownNCT00923637Phase 2
- Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed)CompletedNCT00916630Phase 1
- Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT00907179Phase 1
- Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung AdenocarcinomaStatus unknownNCT00903292Not applicable
- Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for MesotheliomaTerminatedNCT00895648Phase 2
- Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) MutationsCompletedNCT00891579Phase 2
- A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801)Status unknownNCT00886678Phase 2
- Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid CancerStatus unknownNCT00786552Phase 2
- Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLCStatus unknownNCT00786331Phase 2
- Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly PatientsTerminatedNCT00754364Phase 2
- Pemetrexed Plus Cisplatin for Brain Metastasis of Advanced Non - Small Cell Lung Cancer (NSCLC)CompletedNCT00744900Phase 2
- Pemetrexed Plus Bevacizumab in Non Small Cell Lung CancerCompletedNCT00741221Phase 2
- Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918TerminatedNCT00733031Phase 1
- Study of Pemetrexed to Treat Recurrent or Progressive Primary Central Nervous System LymphomaWithdrawnNCT00712062Phase 2
- Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung CancerTerminatedNCT00705549Phase 2
- Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction CancerCompletedNCT00701857Phase 1
- Study of TRC102 in Combination With Pemetrexed in Cancer PatientsCompletedNCT00692159Phase 1
- Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC)CompletedNCT00684099Phase 1/2
- Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based ChemotherapyCompletedNCT00630149Phase 2
- A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid TumorsCompletedNCT00619424Phase 1
- Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IVCompletedNCT00614965Phase 2
- A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid TumorsCompletedNCT00528619Phase 1
- A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer With an Initial Dose Finding PhaseCompletedNCT00528281Phase 1
- Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated With Surgery or is MetastaticCompletedNCT00490373Phase 2
- Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With ChemotherapyCompletedNCT00489983Phase 2
- Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus SorafenibTerminatedNCT00473486Phase 1/2
- Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)CompletedNCT00440414Phase 3
- Safety of Everolimus and Pemetrexed in Lung Cancer PatientsCompletedNCT00434174Phase 1
- Alimta and Gemcitabine in Non-Small Cell Lung CancerCompletedNCT00434135Phase 2
- Pemetrexed in Patients With Soft Tissue SarcomaCompletedNCT00427466Phase 2
- Pemetrexed in Patients With Advanced Neuroendocrine TumorsCompletedNCT00424723Phase 2
- Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal MetastasesCompletedNCT00424242Early Phase 1
- Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung CancerCompletedNCT00408226Phase 1/2
- Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural MesotheliomaCompletedNCT00407459Phase 2
- Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant MesotheliomaCompletedNCT00402766Phase 1
- Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid TumorsCompletedNCT00390000Phase 1
- Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by SurgeryTerminatedNCT00389688Phase 2
- Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsCompletedNCT00387322Phase 1/2
- Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural MesotheliomaCompletedNCT00386815Phase 2
- Trial on Refinement of Early Stage Lung Cancer Adjuvant TherapyCompletedNCT00349089Phase 2
- Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior TherapyCompletedNCT00343720Phase 2
- Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung CancerCompletedNCT00330044Phase 1
- Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung CancerTerminatedNCT00321308Phase 2
- Topotecan in Combination With Pemetrexed in Patients With Advanced MalignanciesCompletedNCT00315861Phase 1
- Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck CancerCompletedNCT00291707Phase 1
- Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based ChemotherapyTerminatedNCT00290017Phase 3
- Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung CancerCompletedNCT00284778Phase 3
- Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain MetastasesStatus unknownNCT00276783Phase 2
- Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00268489Phase 2
- Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT00254319Phase 2
- Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural MesotheliomaCompletedNCT00251550Phase 1/2
- A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLCCompletedNCT00251524Phase 2
- Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian CancerCompletedNCT00230542Phase 2
- Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural MesotheliomaCompletedNCT00227630Phase 2
- Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00227565Phase 2
- Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung CancerTerminatedNCT00216216Phase 2
- A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric CarcinomaCompletedNCT00192088Phase 2
- A Study of Pemetrexed in Small Cell Lung Cancer, Which Has ReturnedCompletedNCT00191750Phase 2
- Gemcitabine and Pemetrexed in Primary Unknown AdenocarcinomaCompletedNCT00191503Phase 2
- A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the LiverCompletedNCT00191412Phase 2
- A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast CancerCompletedNCT00191347Phase 2
- A Trial for Patients With Gestational Trophoblastic DiseaseCompletedNCT00190918Phase 2
- A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung CancerCompletedNCT00190840Phase 2
- Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric CarcinomaCompletedNCT00190801Phase 2
- A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of MesotheliomaCompletedNCT00190762Phase 3
- Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung CancerTerminatedNCT00179699Phase 1
- Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based ChemotherapyCompletedNCT00109096Phase 2
- S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic ChondrosarcomaCompletedNCT00107419Phase 2
- A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast CancerCompletedNCT00102219Phase 2
- Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder CancerCompletedNCT00101842Phase 1/2
- Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00097383Phase 1/2
- Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar PregnancyTerminatedNCT00096187Phase 2
- A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung CancerCompletedNCT00087711Phase 3
- Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the CervixCompletedNCT00087113Phase 2
- Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial CancerCompletedNCT00087100Phase 2
- Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00087087Phase 2